Text
From Financialisation to Innovation in UK Big Pharma: AstraZeneca and GlaxoSmithKline
The tension between innovation and financialisation is central to the business corporation. Innovation entails a 'retain-and-reinvest' allocation regime that can form a foundation for stable and equitable economic growth.
No copy data
No other version available